VEGFA, NODAL, and BMP6 correlated with RCC cell line proliferation and, thus, may represent putative clinical biomarkers for RCC progression as well as for RCC diagnosis and prognosis. The gene discussed is VEGFA; the disease is renal cell adenocarcinoma.